Connecticut 2012 Regular Session

Connecticut House Bill HB05244

Introduced
2/22/12  
Refer
2/22/12  
Report Pass
3/9/12  
Refer
3/16/12  
Report Pass
3/22/12  
Engrossed
3/28/12  
Engrossed
3/28/12  
Report Pass
3/30/12  

Caption

An Act Concerning Collaborative Funding Agreements And The Stem Cell Research Program.

Impact

If enacted, HB 05244 is expected to impact state laws related to health funding and scientific research. By mandating that no less than ten million dollars be made available annually for stem cell research for a specified period, the bill allocates significant resources toward this innovative area of healthcare. Additionally, it empowers the Commissioner of Public Health and the Stem Cell Research Advisory Committee with the authority to direct funding and research initiatives, thereby shaping the State's approach to cutting-edge health solutions.

Summary

House Bill 05244 aims to enhance the State's capabilities in stem cell research by establishing the Stem Cell Research Fund, which will serve as a separate, non-lapsing account within the General Fund. This fund is intended to support embryonic and adult stem cell research by providing grants-in-aid to eligible institutions. The bill emphasizes collaborative funding agreements with various entities, which could include other states or countries, to foster research opportunities and stimulate advancements in the field of stem cell research.

Sentiment

The sentiment surrounding HB 05244 appears to be largely positive, with supporters praising it for its potential to advance medical research and improve public health outcomes. Advocates view the establishment of the Stem Cell Research Fund as a critical investment in health science that could lead to breakthroughs in treatments for various conditions. However, there may also be some concerns among skeptics regarding ethical implications and proper oversight of stem cell research, though these are not elaborated upon in the voting discussions or legislative records.

Contention

While the bill does not appear to have generated significant opposition during the voting process, concerns over the ethical ramifications of stem cell research are often present in legislative discussions around similar bills. In this context, the success of HB 05244 may hinge on the effective establishment of clear guidelines for research practices and transparency in funding allocation, which are crucial for gaining broader support across diverse interest groups.

Companion Bills

No companion bills found.

Similar Bills

CA AB922

Reproductive health and research: oocyte procurement.

HI SB2304

Relating To The Research Corporation Of The University Of Hawaii.

HI SB3208

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1511

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1511

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1204

Relating To The University Of Hawaii.

CA SB934

California Childhood Cancer Research Fund Act.

CA AB1103

Controlled substances: research.